« Previous
Next »
Seminars in Radiation Oncology
Volume 22, Issue 1
, Pages
18-28
, January 2012
What We Have Learned: The Impact of Quality From a Clinical Trials Perspective
-
The QARC benchmark portfolio. Available at www.QARC.org.
The QARC benchmark portfolio. Available at www.QARC.org.
-
The QARC interventional review process.
The QARC interventional review process.
-
The QARC final review process.
The QARC final review process.
-
Relapse-free survival for POG 8725 indicating significantly better results when radiation therapy was in accordance with protocol specifications.
Relapse-free survival for POG 8725 indicating significantly better results when radiation therapy was in accordance with protocol specifications.
-
HeadSTART trial results (overall survival) by protocol deviation status.
HeadSTART trial results (overall survival) by protocol deviation status.
-
HeadSTART trial results (failure-free survival) by protocol deviation status.
HeadSTART trial results (failure-free survival) by protocol deviation status.
Supported in part by NIH/NCI CA 29511 (Quality Assurance Review Center).
PII: S1053-4296(11)00095-6
doi: 10.1016/j.semradonc.2011.09.004
© 2012 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Radiation Oncology
Volume 22, Issue 1
, Pages
18-28
, January 2012
